RelB is a potential molecular biomarker for immunotherapy in human pan-cancer

Introduction: The nuclear factor kB (NF-κB) pathway emerges as a critical regulator of immune responses and is often dysregulated in human cancers. It consists of a family of transcription factors involved in many biological responses. Activated NF-κB subunits results in the nuclear translocation an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jintao, Yu, Xinyu, Zhu, Hongyu, Chen, Peng, Liu, Tongyan, Yin, Rong, Qiang, Yan, Xu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303125/
https://www.ncbi.nlm.nih.gov/pubmed/37388242
http://dx.doi.org/10.3389/fmolb.2023.1178446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303125/
https://www.ncbi.nlm.nih.gov/pubmed/37388242
http://dx.doi.org/10.3389/fmolb.2023.1178446

Ejemplares similares